Cross-fund · 4 holders
TCRX
TSCAN THERAPEUTICS INC
CUSIP 89854M101
4
Tracked holders
$6.1M
Aggregate value
6,095,381
Shares
5
Active funds
Funds holding TCRX
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $2.5M | — | +157,817 | +6.8% |
| BlackRock | Institutional | Q1 2026 | $1.9M | — | -7,743 | -0.4% |
| Millennium | Multi-Strategy | Q1 2026 | $1.5M | — | +1,056,667 | +261.8% |
| Citadel | Multi-Strategy | Q1 2026 | $321,596 | — | +155,534 | +95.5% |
| Point72FEAT | Multi-Strategy | Q1 2026 | — | — | -14,512 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.